United States - Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 20 December 2019
- Opportunity publication date
- 05 November 2019
- Value of contract
- to be confirmed
- Your guide to exporting
Description
Added: Nov 04, 2019 10:07 am
Background:
The Department of Defense (DoD) is required by law (10 U.S.C. ยง 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.
P&T COMMITTEE MEETING: February 2020: The following drug classes/subclass and agents will be reviewed:
Pain Agents, SUB CLASS: NSAID
Pain Agents, SUB CLASS: PAIN TOPICAL
RFQ: The RFQ, including UF BPA and UF ADP appendices are attached herein. The historical utilization data
including quantity dispensed and 30 day equivalents by mouth is also attached herein.
PRE-Proposal Conference: See Paragraphs 2.4 and 2.5 of the RFQ. Minutes will be posted herein.
POCs: Part 2.3 of the RFQ.
For additional information, search DoD Pharmacy and Therapeutics (P&T) Committee at http://www.health.mil/POD
- Opportunity closing date
- 20 December 2019
- Value of contract
- to be confirmed
About the buyer
- Address
- Other Defense Agencies Managed Care Contracting Division United States
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.